Role of immunity of maternal-infant HIV-1 transmission

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 421, 1997, Pages 39-45

  Jansson, M ^a,b   Orlandi, P ^b   Scarlatti, G ^c   Moschese, V ^b   Romiti, M L ^b   Cancrini, C ^b   Mancia, L ^b   Livadiotti, S ^d   Castelli Gattinara, G ^d   Rossi, P ^a,b   Halapi, E ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

HIV 1 mother to child transmission; Immunization; Neutralizing antibodies; Virus genotype

Indexed keywords

GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY;

ACTIVE IMMUNIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOTHERAPY; PASSIVE IMMUNIZATION; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SYNCYTIUM; VERTICAL TRANSMISSION; VIRUS GENOME; VIRUS TITRATION;

EID: 0030745324     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. World Health Organization. AIDS-global data. The global situation of the HIV/AIDS pandemic. Weekly Empidemiol Rec 1994; 69: 189-92
2. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-22
3. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332: 201-8
4. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-6
5. Coffin JM. HIV population dynamics m vivo: implications for genetic variation, pathogenesis and therapy. Science 1995; 267: 483-9
6. Tovo PA, Palomba E, Gabiano C, Galli L, et al. HIV-1 seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynecol 1991; 98: 940-2
7. Dunn DT, Newell ML, Ades AE, Peckham C. Risk of HIV-1 transmission through breastfeeding. Lancet 1992; 340: 585-8
8. Centers for Disease Control. Zidovudine for the prevention of HIV transmission from mother to infant. Morbid Mortal Weekly Rep 1994; 43: 285-7
9. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994; 271: 1925-30
10. Scarlatti G, Hodara V, Rossi P, et al. Transmission of HIV-1 from mother-to-child correlates with viral phenotype. Virology 1993; 197: 624-9
11. Asjo B, Morfeldt-Manson L, Albert J, et al. Replicative capacity of HIV from patients with varying severity of HIV infection. Lancet 1986; ii: 660-2
12. Connor RI, Mohn H, Cao Y, Ho DD. Increased viral burden and cythopathicity correlate temporally with CD4 T-lymphocyte decline and clinical progression in HIV-1 infected individuals. J Virol 1993; 67: 1772-7
13. Koot M, Vos AHV, Keet RPM, et al. HIV-1 Biological phenotype in long-term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992; 6: 49-54
14. Goudsmit J. The role of viral diversity in HIV pathogenesis. J Acq Immune Defic 1995; 10 Suppl 1: S15-9
15. Simmonds P, Zhang LQ, Me Omish F, et al. Discontinuos sequence change of HIV-1 env sequences in plasma viral and lymphocyte-associated proviral populations m vivo>: implications for models of HIV pathogenesis. J Virol 1991; 65: 6266-76
16. Wolfs T, de Jong J, Van den Berg H, et al. Evolution of sequences encoding the principal neutralizing epitope of HIV-1 is host-dependent, rapid and continuous. Proc Natl Acad Sci USA 1990; 87: 9938-42
17. Freed E, Myers D, Risser R. Identification of the principal neutralizing determinant of HIV-1 as a fusion domain. J Virol 1991; 65: 190-3
18. Hwang SS, Boyle TJ, Lyerly K, et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253: 71-4
19. Cheinsong-Popov R, Lister S, Callow D, et al. Serotyping HIV-1 by antibody binding to the V3 loop: relationship to viral genotype. WHO network for HIV isolation and characterization. AIDS Res Hum Retrovir 1994; 10: 1379-86
20. Jansson M, Wahren B, Albert J, et al. Peptide serology for analysis of intra- and interindividual variation in the V3 domain. AIDS 1994; 8: 413-21
21. Simmonds P, Balfe P, Ludlom CA, et al. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of HIV-1. J Virol 1990; 64: 5840-50
22. Wolinski SM, Wike CM, Korber BTM, et al. Selective transmission of HIV-1 variants from mother-to-infants. Science 1992; 255: 1134-7
23. Scarlatti G, Leitner T, Halapi E, et al. Comparison of variable region 3 sequences of HIV-1 from infected children with the RNA and DNA sequences of the virus population of their mothers. Proc Natl Acad Sci USA 1993; 90: 1721-5
24. Muldre-Kampinga GA, Kuiken C, Dekker J, et al. Genomic HIV-1 RNA variation in mother and child following intra-uterine virus transmission. J Gen Virol 1993; 74: 1747-56
25. Lamers SL, Sleasman JW, She JW, et al. Persistence of multiple maternal genotypes of HIV-1 in infants infected by vertical transmission. J Clin Invest 1994; 93: 380-90
26. Haynes BF, Pantaleo G, Fauci AS. Towards an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271: 324-8
27. Zinkernagel RM. Immunology taught by viruses. Science 1996; 271: 173-8
28. Ljunggren K, Moschese V, Broliden PA, et al. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children bom to HIV-infected mothers. J Infect Dis 1990; 161: 198-202
29. Broliden K, Sievers E, Tovo PA, et al. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1 infected mothers and their children. Clin Exp Immunol 1993; 93: 56-64
30. van de Perre P, Lepage P, Simonon A, et al. Biological markers associated with prolonged survival in African children maternally infected by the HIV-1. AIDS Res Hum Retrovir 1992; 8: 435-41
31. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of HIV-1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993; 168: 207-10
32. Lukashov VV, Kuiken C, Goudsmit J, etal. Intrahost HIV-l evolution is related to the length of the immunocompetent period. J Virol. Submitted for publication
33. Thompson C. Can some infants beat HIV? Science 1996; 271: 441
34. Bryson YJ, Pang S, Wei LS, et al. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995; 332: 833-8
35. Roques PA, Gras G, Parnet-Mathieu F, et al. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 1995; 9: F19-26
36. Pauza D. J Med Primatol 1993; 22: 154-7
37. Kirchoff F, Greenough JC, Drettler DB, et al. Absence of intact nef-sequences in a long-term survivor with non-progressive HIV infection. N Engl J Med 1995; 332: 228-32
38. Rowland Jones S, Sutlon J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995; 1: 59-64
39. Travers K, Mboup S, Marlink R, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995; 268: 1612-5
40. Stiehm ER, Mofenson L, Zolla-Pazner, et al. Meeting Report. Summary of the Workshop on Passive Immunotherapy in the prevention and treatment of HIV infection. Clin Immunol Immunopathol 1995; 75: 84-93
41. Dolin R. Human studies in the development of HIV vaccines. J Infect Dis 1995; 172: 1175-83
42. Jelonek MT, Maskrey JL, Steimer KS, et al. Inhibition of the offspring anti-recombinant gp 120 antibody response to a human immunodeficiency virus vaccine by maternal immunization in a murine model. J Infect Dis 1995; 172: 539-42